BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31285528)

  • 21. Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone.
    Lutsik P; Baude A; Mancarella D; Öz S; Kühn A; Toth R; Hey J; Toprak UH; Lim J; Nguyen VH; Jiang C; Mayakonda A; Hartmann M; Rosemann F; Breuer K; Vonficht D; Grünschläger F; Lee S; Schuhmacher MK; Kusevic D; Jauch A; Weichenhan D; Zustin J; Schlesner M; Haas S; Park JH; Park YJ; Oppermann U; Jeltsch A; Haller F; Fellenberg J; Lindroth AM; Plass C
    Nat Commun; 2020 Oct; 11(1):5414. PubMed ID: 33110075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Giant-cell-poor giant cell tumor of bone: report of two cases and literature review.
    Yakoub MA; Torrence D; Hwang S; Bartelstein M; Healey JH; Hameed M
    Skeletal Radiol; 2023 Sep; 52(9):1791-1798. PubMed ID: 36781420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India.
    Kamble A; Hui M; Rao KN; Narayanan R; Reddy BR; Uppin SG; Chandrasekhar P
    Indian J Pathol Microbiol; 2022; 65(3):617-629. PubMed ID: 35900490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
    Ratnagiri R; Uppin S
    J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases.
    Yang L; Zhang H; Zhang X; Tang Y; Wu Z; Wang Y; Huang H; Fu X; Liu J; Hogendoorn PCW; Cheng H
    Ann Diagn Pathol; 2022 Apr; 57():151882. PubMed ID: 34995868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors.
    Nohr E; Lee LH; Cates JM; Perizzolo M; Itani D
    Hum Pathol; 2017 Oct; 68():119-127. PubMed ID: 28882701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Utility of Genetic and Immunohistochemical
    Wągrodzki M; Tysarowski A; Seliga K; Wojnowska A; Stepaniuk M; Castañeda Wysocka P; Makuła D; Pieńkowski A; Szostakowski B; Zub R; Rutkowski P
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach.
    Kervarrec T; Collin C; Larousserie F; Bouvier C; Aubert S; Gomez-Brouchet A; Marie B; Miquelestorena-Standley E; Le Nail LR; Avril P; Christophe Pagès J; de Pinieux G
    Mod Pathol; 2017 Mar; 30(3):393-406. PubMed ID: 28059095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Giant-cell tumor of bone in 2022].
    Larousserie F; Audard V; Burns R; de Pinieux G
    Ann Pathol; 2022 Apr; 42(3):214-226. PubMed ID: 35523609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of H3.3 G34W mutant-specific antibody in giant cell tumors of bone and its diagnostic value].
    Wang X; Wu N; Zhang RS; Wei X; Ji RH; Ma HH; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):116-121. PubMed ID: 32074722
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of H3F3A p.G35W and p.G35R in giant cell tumor of bone by Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR).
    Gamberi G; Morandi L; Benini S; Resca A; Cocchi S; Magagnoli G; Donati DM; Righi A; Gambarotti M
    Pathol Res Pract; 2018 Jan; 214(1):89-94. PubMed ID: 29254795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [H3F3A mutated multicentric giant cell tumor of bone : A very rare primary bone disease].
    Giesche JP; von Baer A; Breining T; Marienfeld R; Mellert K; Lüke J; Schultheiss M; Möller P; Barth TFE
    Pathologe; 2018 Sep; 39(5):451-456. PubMed ID: 30046846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing.
    Lim J; Park JH; Baude A; Yoo Y; Lee YK; Schmidt CR; Park JB; Fellenberg J; Zustin J; Haller F; Krücken I; Kang HG; Park YJ; Plass C; Lindroth AM
    Sci Rep; 2017 Oct; 7(1):13459. PubMed ID: 29044188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Giant cell tumor of soft tissue is genetically distinct from its bone counterpart.
    Lee JC; Liang CW; Fletcher CD
    Mod Pathol; 2017 May; 30(5):728-733. PubMed ID: 28084336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation.
    Tsukamoto Y; Futani H; Kihara T; Watanabe T; Kumanishi S; Matsuo S; Hirota S; Ueda T; Yamamoto H; Yoshiya S
    Pathol Res Pract; 2018 Sep; 214(9):1504-1509. PubMed ID: 29970305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Giant cell tumor of bone: updated molecular pathogenesis and tumor biology.
    Noh BJ; Park YK
    Hum Pathol; 2018 Nov; 81():1-8. PubMed ID: 29944971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Three Novel H3F3A-mutated Giant Cell Tumor Cell Lines and Targeting of Their Wee1 Pathway.
    Lübbehüsen C; Lüke J; Seeling C; Mellert K; Marienfeld R; von Baer A; Schultheiss M; Möller P; Barth TFE
    Sci Rep; 2019 Apr; 9(1):6458. PubMed ID: 31015476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of
    Luo Y; Tang J; Huang J; Hu D; Bai Y; Chen J; Sun K; Zhang H; Liu Z
    J Bone Oncol; 2023 Feb; 38():100467. PubMed ID: 36619849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical genomic profiling of malignant giant cell tumor of bone: A retrospective analysis using a real‑world database.
    Tsuda Y; Okajima K; Ishibashi Y; Zhang L; Hirai T; Kage H; Shinozaki-Ushiku A; Oda K; Tanaka S; Kobayashi H
    Med Int (Lond); 2024; 4(2):17. PubMed ID: 38476985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation.
    Hasenfratz M; Mellert K; Marienfeld R; von Baer A; Schultheiss M; Roitman PD; Aponte-Tinao LA; Lehner B; Möller P; Mechtersheimer G; Barth TFE
    Sci Rep; 2021 Mar; 11(1):5709. PubMed ID: 33707617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.